Suppr超能文献

慢性大麻使用的作用:周期性呕吐综合征与大麻素呕吐综合征。

Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.

机构信息

Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

出版信息

Neurogastroenterol Motil. 2019 Jun;31 Suppl 2(Suppl 2):e13606. doi: 10.1111/nmo.13606.

Abstract

Cannabis is commonly used in cyclic vomiting syndrome (CVS) due to its antiemetic and anxiolytic properties. Paradoxically, chronic cannabis use in the context of cyclic vomiting has led to the recognition of a putative new disorder called cannabinoid hyperemesis syndrome (CHS). Since its first description in 2004, numerous case series and case reports have emerged describing this phenomenon. Although not pathognomonic, a patient behavior called "compulsive hot water bathing" has been associated with CHS. There is considerable controversy about how CHS is defined. Most of the data remain heterogenous with limited follow-up, making it difficult to ascertain whether chronic cannabis use is causal, merely a clinical association with CVS, or unmasks or triggers symptoms in patients inherently predisposed to develop CVS. This article will discuss the role of cannabis in the regulation of nausea and vomiting, specifically focusing on both CVS and CHS, in order to address controversies in this context. To this objective, we have collated and analyzed published case series and case reports on CHS in order to determine the number of reported cases that meet current Rome IV criteria for CHS. We have also identified limitations in the existing diagnostic framework and propose revised criteria to diagnose CHS. Future research in this area should improve our understanding of the role of cannabis use in cyclic vomiting and help us better understand and manage this disorder.

摘要

大麻由于其止吐和抗焦虑特性,常用于周期性呕吐综合征(CVS)。具有讽刺意味的是,在周期性呕吐的情况下慢性大麻使用导致了一种被称为大麻素过度呕吐综合征(CHS)的假定新疾病的出现。自 2004 年首次描述以来,已经出现了许多描述这种现象的病例系列和病例报告。尽管不是特征性的,但有一种称为“强迫热水浴”的患者行为与 CHS 相关。关于如何定义 CHS 存在相当大的争议。大多数数据仍然存在异质性,随访时间有限,难以确定慢性大麻使用是否是因果关系,仅是与 CVS 的临床关联,还是在本来就容易患上 CVS 的患者中揭示或引发症状。本文将讨论大麻在调节恶心和呕吐中的作用,特别是针对 CVS 和 CHS,以解决这方面的争议。为此,我们收集和分析了关于 CHS 的已发表病例系列和病例报告,以确定符合当前罗马 IV 标准的 CHS 报告病例数。我们还确定了现有诊断框架中的局限性,并提出了诊断 CHS 的修订标准。该领域的未来研究应能提高我们对大麻使用在周期性呕吐中的作用的理解,并帮助我们更好地理解和管理这种疾病。

相似文献

1
Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.
Neurogastroenterol Motil. 2019 Jun;31 Suppl 2(Suppl 2):e13606. doi: 10.1111/nmo.13606.
3
Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Am J Emerg Med. 2013 Jun;31(6):1003.e5-6. doi: 10.1016/j.ajem.2013.02.021. Epub 2013 Apr 10.
4
Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
Am J Ther. 2018 May/Jun;25(3):e357-e361. doi: 10.1097/MJT.0000000000000655.
5
The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
Clin Toxicol (Phila). 2019 Sep;57(9):773-777. doi: 10.1080/15563650.2018.1564324. Epub 2019 Feb 7.
6
Cannabinoid hyperemesis syndrome.
Curr Drug Abuse Rev. 2011 Dec;4(4):241-9. doi: 10.2174/1874473711104040241.
7
Patterns of Cannabis Use in Patients With Cyclic Vomiting Syndrome.
Clin Gastroenterol Hepatol. 2020 May;18(5):1082-1090.e2. doi: 10.1016/j.cgh.2019.07.039. Epub 2019 Jul 25.
9
Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update.
Eur J Gastroenterol Hepatol. 2022 Jan 1;34(1):1-8. doi: 10.1097/MEG.0000000000001992.
10
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.
J Med Toxicol. 2017 Mar;13(1):71-87. doi: 10.1007/s13181-016-0595-z. Epub 2016 Dec 20.

引用本文的文献

1
Cannabinoid Hyperemesis Syndrome Presenting as Postoperative Nausea and Vomiting in a Chronic Cannabis User: A Case Report.
Cureus. 2025 Jul 15;17(7):e87990. doi: 10.7759/cureus.87990. eCollection 2025 Jul.
2
Cannabinoid Hyperemesis Syndrome in Adolescents: A Narrative Review.
Pediatr Rep. 2025 Jul 14;17(4):75. doi: 10.3390/pediatric17040075.
4
Review of cannabis use and propofol anesthesia: recent insights and clinical implications.
Curr Opin Anaesthesiol. 2025 Jul 1. doi: 10.1097/ACO.0000000000001548.
5
Cyclic Vomiting Syndrome Versus Cannabinoid Hyperemesis Syndrome.
J Neurogastroenterol Motil. 2025 Jul 30;31(3):399-400. doi: 10.5056/jnm25033. Epub 2025 Jun 28.
6
Chasing Highs, Experiencing Lows: A Case of Hypokalemia Associated With Cannabis Use.
Cureus. 2025 Apr 29;17(4):e83194. doi: 10.7759/cureus.83194. eCollection 2025 Apr.
7
The Clinical Conundrum of Cyclic Vomiting in the Cannabinoid User: Simply Cannabinoid Hyperemesis or Could It Be More?
ACG Case Rep J. 2025 May 21;12(5):e01711. doi: 10.14309/crj.0000000000001711. eCollection 2025 May.
8
Cannabis Hyperemesis Syndrome in Youth: Clinical Insights and Public Health Implications.
Int J Environ Res Public Health. 2025 Apr 17;22(4):633. doi: 10.3390/ijerph22040633.
9
The Importance of Accurate Drug Use History in Diagnosing and Managing Cannabinoid Hyperemesis Syndrome: A Case Report.
Cureus. 2025 Mar 10;17(3):e80352. doi: 10.7759/cureus.80352. eCollection 2025 Mar.
10
Cannabinoid Hyperemesis Syndrome: A Rising Complication.
Cureus. 2025 Feb 13;17(2):e78958. doi: 10.7759/cureus.78958. eCollection 2025 Feb.

本文引用的文献

1
Patterns of Cannabis Use in Patients With Cyclic Vomiting Syndrome.
Clin Gastroenterol Hepatol. 2020 May;18(5):1082-1090.e2. doi: 10.1016/j.cgh.2019.07.039. Epub 2019 Jul 25.
3
Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults.
Clin Gastroenterol Hepatol. 2019 Apr;17(5):878-886. doi: 10.1016/j.cgh.2018.05.020. Epub 2018 May 29.
4
Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):741-753. doi: 10.1136/jnnp-2017-317168. Epub 2018 Mar 6.
5
Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.
ACG Case Rep J. 2018 Jan 3;5:e3. doi: 10.14309/crj.2018.3. eCollection 2018.
6
The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana Smokers in an Urban Public Hospital.
Basic Clin Pharmacol Toxicol. 2018 Jun;122(6):660-662. doi: 10.1111/bcpt.12962. Epub 2018 Feb 23.
7
Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network.
Drug Alcohol Depend. 2018 Jan 1;182:27-32. doi: 10.1016/j.drugalcdep.2017.09.038. Epub 2017 Nov 7.
8
Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
Pediatrics. 2017 Dec;140(6). doi: 10.1542/peds.2016-3795. Epub 2017 Nov 9.
9
Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013.
J Clin Gastroenterol. 2018 Oct;52(9):778-783. doi: 10.1097/MCG.0000000000000944.
10
Cannabinoid Receptor 1 Gene by Cannabis Use Interaction on CB1 Receptor Density.
Cannabis Cannabinoid Res. 2017 Aug 1;2(1):202-209. doi: 10.1089/can.2017.0007. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验